Studying stem cells and blood patterns in glioblastoma
Part of Cancer clinical trials.
This study analyzes tissue and health-related biological data from people with glioblastoma to learn what’s happening in the tumor. The results may help improve future ways to understand and treat glioblastoma using advanced computer analysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a brain tumor diagnosis called glioblastoma in the upper part of the brain (supratentorial).
- Your case is either first diagnosis or a documented first recurrence after earlier glioblastoma surgery.
- Your doctors believe neurosurgery is a suitable option for you at this center.
- You are age 18 or older.
- You can sign a consent form saying you agree to join the study.
- The surgery tissue sample must be enough for routine testing and for this research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether certain details on brain scans can help doctors better predict how brain cancer (glioblastoma) will progress. You may be eligible if you are newly diagnosed with this type of cancer and plan to receive standard treatment.
This trial is for people with glioma who have tumor tissue or blood samples stored. It uses artificial intelligence to analyze these samples and find the best treatment. You might be eligible if you are at least 18 years old and have had a glioma diagnosis with tissue available for study.
This study follows people newly diagnosed with glioblastoma to see how certain lab signals (MMP2 and MMP9) match up with MRI scan features. It may help doctors better understand the disease and how it appears on imaging, but it’s mainly observational.
This study looks at whether brain scans (MRI, PET/CT) can help predict the genetic makeup of glioblastoma, without needing more tissue samples. If you join, you'll get advanced imaging to better understand your tumor and guide future treatment decisions.
This study is testing whether special MRI scans and blood tests can help tell the difference between true tumor growth (progression) and a treatment-related reaction called 'pseudoprogression' in people with glioblastoma. The goal is to make treatment decisions more accurate.
This study looks at the chemicals and genes in brain tumors called gliomas to find better ways to diagnose and treat them. People with a brain mass that needs surgery may be able to join.
Hear when a new Glioblastoma, IDH-wildtype trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.